GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 49.13%
This Quarter Est. Return
1 Year Est. Return
+49.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$276M
AUM Growth
-$11.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1 +$13.1M
2 +$9.25M
3 +$8.12M
4
JANX icon
Janux Therapeutics
JANX
+$6.36M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$5.2M

Top Sells

1 +$17M
2 +$11.7M
3 +$8.65M
4
PCVX icon
Vaxcyte
PCVX
+$8M
5
SLNO icon
Soleno Therapeutics
SLNO
+$7.57M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
1
Sarepta Therapeutics
SRPT
$2.44B
$15M 4.53%
120,000
+65,000
NVO icon
2
Novo Nordisk
NVO
$249B
$13.1M 3.96%
+110,000
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$12.9M 3.91%
140,000
+100,000
AXSM icon
4
Axsome Therapeutics
AXSM
$6.24B
$12.1M 3.66%
135,000
-15,000
TARS icon
5
Tarsus Pharmaceuticals
TARS
$3.16B
$11.5M 3.48%
350,000
+115,000
CATX icon
6
Perspective Therapeutics
CATX
$353M
$10M 3.02%
750,000
-175,000
CGON icon
7
CG Oncology
CGON
$3.19B
$9.43M 2.85%
250,000
-10,000
ROIV icon
8
Roivant Sciences
ROIV
$11.7B
$9.23M 2.79%
800,000
-200,000
PCVX icon
9
Vaxcyte
PCVX
$5.66B
$9.14M 2.76%
80,000
-70,000
VKTX icon
10
Viking Therapeutics
VKTX
$3.91B
$8.86M 2.68%
140,000
+45,000
SNDX icon
11
Syndax Pharmaceuticals
SNDX
$1.3B
$8.66M 2.62%
450,000
+100,000
JANX icon
12
Janux Therapeutics
JANX
$1.63B
$8.63M 2.61%
190,000
+140,000
ASND icon
13
Ascendis Pharma
ASND
$12.5B
$7.84M 2.37%
52,500
-34,221
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$3.98B
$7.67M 2.32%
150,000
-90,000
SLNO icon
15
Soleno Therapeutics
SLNO
$3.61B
$7.57M 2.29%
150,000
-150,000
TGTX icon
16
TG Therapeutics
TGTX
$5.53B
$7.25M 2.19%
310,000
-190,000
RZLT icon
17
Rezolute
RZLT
$806M
$7.15M 2.16%
1,474,995
+53,494
PHAT icon
18
Phathom Pharmaceuticals
PHAT
$944M
$6.78M 2.05%
375,000
-225,000
MLTX icon
19
MoonLake Immunotherapeutics
MLTX
$596M
$6.47M 1.96%
128,411
-171,589
OLMA icon
20
Olema Pharmaceuticals
OLMA
$659M
$6.39M 1.93%
535,000
-15,000
IMVT icon
21
Immunovant
IMVT
$3.03B
$6.13M 1.85%
215,000
-45,000
INSM icon
22
Insmed
INSM
$34.5B
$5.47M 1.65%
75,000
+10,000
EWTX icon
23
Edgewise Therapeutics
EWTX
$1.61B
$5.2M 1.57%
+195,000
REPL icon
24
Replimune Group
REPL
$365M
$4.93M 1.49%
450,000
BBIO icon
25
BridgeBio Pharma
BBIO
$10.5B
$4.46M 1.35%
175,000
+35,000